TRIP15 Antibodies

Santa Cruz Biotechnology features a diverse variety of TRIP15 monoclonal antibodies for research focused on understanding TRIP15's role in cellular processes. TRIP15 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TRIP15, also known as the thyroid hormone receptor interactor 15, plays a crucial role in regulating protein degradation and cellular signaling pathways. TRIP15 functions within the ubiquitin-proteasome system, which is essential for maintaining cellular homeostasis and regulating various biological processes, including cell cycle progression and apoptosis. Research has shown that TRIP15 expression levels can vary significantly across different tissue types and developmental stages. Scientists continue to uncover new functions of TRIP15 in both normal cellular processes and disease states. Understanding TRIP15's molecular mechanisms has become increasingly important for developing therapeutic strategies for cancer and metabolic disorders. Investigating TRIP15's interactions with other proteins provides valuable insights into cellular regulatory networks. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TRIP15's role in human health and disease.